Spend 500 for 30% off Product Overview AOD9604 is a synthetic 16-amino-acid peptide derived from the C-terminal region of human growth hormone, commonly described as the hGH 176191 fragment with an added N-terminal tyrosine, supplied as a 5mg white to off-white lyophilised solid intended strictly for laboratory research and in vitro evaluation
According to CMS billing guidance (Medicare Article A57755), the primary covered indications are pernicious anemia, documented cobalamin deficiency with laboratory evidence, and malabsorption syndromes that prevent adequate oral B12 absorption
Side effects are generally rare but may include mild injection site reactions or discomfort
The GHK-Cu injection guide walks through several reconstitution scenarios
In many instances, providers must determine whether prior authorization is needed, depending on the patients insurance, including Medicare